Table 2.
First-step replication: OM sample | ||||||
---|---|---|---|---|---|---|
CNV | Chr | Freq | P BMI | βa | P body fat mass | βa |
CNV1670 | 10q26.3 | 0.036 | 0.0465 | 1.620 | 0.0435 | 2.728 |
CNV1669 | 10q26.3 | 0.036 | 0.0465 | 1.620 | 0.0435 | 2.728 |
CNV1834 | 12p11.21 | 0.104 | 0.0510 | −0.892 | 0.0640 | −1.378 |
CNV12144 | 14q11.2 | 0.049 | 0.3220 | −0.326 | 0.4840 | 0.048 |
CNV2200 | 16q23.1 | 0.012 | 0.1360 | −1.550 | 0.2440 | −1.785 |
Second-step replication for CNV10q26.3 (CNV1670 and CNV1669) | ||||||
---|---|---|---|---|---|---|
FHS sample |
AA sample |
|||||
Freq | P BMI | P body fat mass | Freq cases | Freq controls | P obesity | OR (95% CI) |
0.046 | 0.0038 | 0.593 | 0.061 | 0.037 | 0.0023 | 1.69 (1.21–2.37) |
All P values listed in Table 2 are two-sided raw P values from the association tests. Chr, Chromosome; Freq, frequency for subjects with abnormal copy numbers; OR, odds ratio; CI, confidence interval.
For β, the effect sizes were estimated in kilograms per square meter for BMI and kilograms for body fat mass.